Home / Inspections / 1303158

FDA Inspection 1303158 — UF Reproductive Medicine at Springhill

UF Reproductive Medicine at Springhill — FEI 3003926999

The FDA completed an inspection of UF Reproductive Medicine at Springhill on February 9, 2026 in Gainesville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 9, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Gainesville, FL (United States)

Facility

Other inspections at this facility

  • 1191870 (NAI Mon Nov 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1092804 (NAI Thu Jun 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 987875 (NAI Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 895060 (NAI Thu Sep 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 735060 (VAI Mon Jul 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources